Hiroya Hashimoto
About
Hiroya Hashimoto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine.
According to data from OpenAlex, Hiroya Hashimoto has authored 53 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Hiroya Hashimoto's work include Lung Cancer Treatments and Mutations (6 papers), Acute Lymphoblastic Leukemia research (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Hiroya Hashimoto is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Acute Lymphoblastic Leukemia research (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Hiroya Hashimoto collaborates with scholars based in Japan, United States and United Kingdom. Hiroya Hashimoto's co-authors include Tetsuo Ohashi, Tatsuo Hosoya, Toshiyuki Fukao, Michio Ozeki, Akifumi Nozawa, Ryuta Asada, Yutaka Mizushima, Akimasa Sakuma, Yasuhiro Ichikawa and Masato Homma and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
In The Last Decade
Hiroya Hashimoto
45 papers receiving 348 citations
Peers
Hiroya Hashimoto
Lawrence R. Shoemaker United States
Carmen Cristóbal Spain
Pengfei Wen China
Željka Večerić‐Haler Slovenia
Haibin Wang China
Mohamed K M Shakir United States
Yanna Dou China
Shuhei Miura Japan
Mika Terasaki Japan
Citations per year, relative to Hiroya Hashimoto Hiroya Hashimoto (= 1×)
peers
Lawrence R. Shoemaker
Countries citing papers authored by Hiroya Hashimoto
Since
Specialization
Citations
This map shows the geographic impact of Hiroya Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroya Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroya Hashimoto more than expected).
Fields of papers citing papers by Hiroya Hashimoto
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Hiroya Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroya Hashimoto. The network helps show where Hiroya Hashimoto may publish in the future.
Co-authorship network of co-authors of Hiroya Hashimoto
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroya Hashimoto. A scholar is included among the top collaborators of Hiroya Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroya Hashimoto. Hiroya Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Matsumura, Tsuyoshi, Takayasu Fukudome, Yasufumi Motoyoshi, et al.. (2025). Efficacy of tranilast in preventing exacerbating cardiac function and death from heart failure in muscular dystrophy patients with advanced-stage heart failure: a single-arm, open-label, multicenter study. Orphanet Journal of Rare Diseases. 20(1). 13–13.
2.
Suzukawa, Maho, Ken Ohta, M. Sugimoto, et al.. (2024). Identification of exhaled volatile organic compounds that characterize asthma phenotypes: A J-VOCSA study. Allergology International. 73(4). 524–531.
3.
Kogure, Yoshihito, Hiroya Hashimoto, Haruko Daga, et al.. (2024). Pembrolizumab and Pemetrexed for Older Patients With Nonsquamous NSCLC and Programmed Cell Death-Ligand 1 Tumor Proportion Scores of Less Than 50%. JTO Clinical and Research Reports. 6(3). 100784–100784.
4.
Sekimizu, Masahiro, Reiji Fukano, Yuhki Koga, et al.. (2024). Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children’s Cancer Group Multicentre Trial, JPLSG B-NHL-20). BMJ Open. 14(3). e080762–e080762.
5.
Kusumoto, Shigeru, Hiroya Hashimoto, Tomotaka Suzuki, et al.. (2024). Low‐dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation. Cancer Medicine. 13(3). e6815–e6815.
6.
Onozawa, Masahiro, Shigeru Kusumoto, Yuho Najima, et al.. (2024). Outcomes of Cessation of Nucleos(t)ide Analog Administration on Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective Study. Transplantation and Cellular Therapy. 30(3). 330.e1–330.e8.
7.
Taguchi, Kazumi, Tatsuya Hattori, Rei Unno, et al.. (2024). Defining a learning curve for urology trainees to achieve renal access without complications in endoscopic combined intrarenal surgery. International Journal of Urology. 31(9). 1046–1051.
8.
Nakanishi, Toshiyuki, Ryuji Nakamura, Hiroya Hashimoto, et al.. (2023). Combined use of the ProSeal laryngeal mask airway and a bronchial blocker vs. a double-lumen endobronchial tube in thoracoscopic surgery: A randomized controlled trial. Journal of Clinical Anesthesia. 88. 111136–111136.
9.
Shimokawahara, Hiroto, Takumi Inami, Kayoko Kubota, et al.. (2023). Protocol for a multicentre, double-blind, randomised, placebo-controlled trial of riociguat on peak cardiac index during exercise in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty (THERAPY-HYBRID-BPA trial). BMJ Open. 13(7). e072241–e072241.
10.
Sasada, Shinsuke, Naoto Kondo, Hiroya Hashimoto, et al.. (2023). Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer. Breast Cancer Research and Treatment. 202(3). 473–483.
11.
Maeda, Shinji, et al.. (2023). High-dimensional analysis of T-cell profiling variations following belimumab treatment in systemic lupus erythematosus. Lupus Science & Medicine. 10(2). e000976–e000976.
12.
Hagiwara, Hiromi, Hiroya Hashimoto, Shigeru Kusumoto, et al.. (2023). Risk factors associated with overall survival in patients with multiple myeloma following carfilzomib treatment: A retrospective study from a large claims database in Japan. Cancer Medicine. 12(19). 19361–19371.
13.
Nakayama, Hideki, Chitose Ogawa, Masahiro Sekimizu, et al.. (2022). A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1). International Journal of Hematology. 116(4). 612–621.
14.
Saito, Toshio, Hiroya Hashimoto, Katsuhisa Ogata, et al.. (2022). Safety and immunogenicity of mRNA COVID ‐19 vaccine in inpatients with muscular dystrophy. Muscle & Nerve. 67(2). 117–123.
15.
Kogure, Yoshihito, Akiko Kada, Hiroya Hashimoto, et al.. (2022). 1160P Survival impact of second-line immune checkpoint inhibitors in the elderly patients with advanced squamous non-small cell lung cancer: Post-hoc analysis from a CAPITAL study. Annals of Oncology. 33. S1079–S1079.
16.
Okuyama, Toru, Tatsuo Akechi, Shigeru Kusumoto, et al.. (2021). Symptoms and health-related quality of life in patients with newly diagnosed multiple myeloma: a multicenter prospective cohort study. Japanese Journal of Clinical Oncology. 52(2). 163–169.
17.
Kida, Daihei, Hiroya Hashimoto, Noriko Ito, et al.. (2021). Patient-Specific Femoral Guide with 3-Dimensional Support Software in Anterolateral Supine Approach of Total Hip Arthroplasty: A Single-Arm Trial. The Kurume Medical Journal. 68(1). 1–8.
18.
Hagiwara, Hiromi, Hidekatsu Fukuta, Hiroya Hashimoto, et al.. (2020). A comparison of the safety and effectiveness of prasugrel and clopidogrel in younger population undergoing percutaneous coronary intervention: A retrospective study using a Japanese claims database. Journal of Cardiology. 77(3). 285–291.
19.
Furui, Tatsuro, Yasushi Takai, Fuminori Kimura, et al.. (2018). [Current Status of Oncofertility in Adolescent and Young Adult (AYA) Generation Cancer Patients in Japan - National Survey of Oncologists].. PubMed. 45(5). 841–846.
20.
Hashimoto, Hiroya & Takahiro Tsuchiya. (2017). Stability problems for Cantor stochastic differential equations. Stochastic Processes and their Applications. 128(1). 211–232.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Lawrence R. Shoemaker Breakdown of academic impact, for papers by Carmen Cristóbal Breakdown of academic impact, for papers by Pengfei Wen Breakdown of academic impact, for papers by Željka Večerić‐Haler Breakdown of academic impact, for papers by Haibin Wang Breakdown of academic impact, for papers by Mohamed K M Shakir Breakdown of academic impact, for papers by Yanna Dou Breakdown of academic impact, for papers by Shuhei Miura Breakdown of academic impact, for papers by Cristian González‐Guerrero Breakdown of academic impact, for papers by Mika Terasaki